• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Introduction to 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester (CAS No. 1465782-87-9)

2-Thiazolecarboxylic acid, 4-chloro-, methyl ester, identified by the Chemical Abstracts Service Number (CAS No.) 1465782-87-9, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the thiazole derivatives, a class of heterocyclic compounds that have garnered considerable attention due to their diverse biological activities and potential applications in medicinal chemistry. The structural motif of thiazole, characterized by a sulfur atom and a nitrogen atom in a six-membered ring, contributes to its unique chemical properties and biological interactions.

The molecular structure of 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester features a chlorinated thiazole core, which is further functionalized with a methyl ester group at the 2-position and a carboxylic acid moiety at the 4-position. This specific arrangement of substituents imparts distinct reactivity and pharmacological profiles, making it a valuable intermediate in the synthesis of more complex molecules. The presence of the chloro substituent enhances electrophilicity, facilitating nucleophilic substitution reactions, while the ester group can be hydrolyzed to yield the corresponding carboxylic acid, offering versatility in synthetic pathways.

In recent years, thiazole derivatives have been extensively studied for their antimicrobial, anti-inflammatory, antiviral, and anticancer properties. The structural framework of 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester aligns well with these pharmacophoric requirements, making it a promising scaffold for drug discovery programs. Specifically, modifications at the 4-position and 2-position of the thiazole ring have been shown to modulate binding affinity and selectivity towards biological targets. For instance, studies have demonstrated that chlorothiazole derivatives exhibit potent activity against certain bacterial strains by interfering with essential metabolic pathways.

One of the most compelling aspects of 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester is its role as a precursor in the synthesis of more elaborate pharmacological agents. Researchers have leveraged its reactive sites to develop novel therapeutic entities targeting various diseases. For example, derivatives of this compound have been investigated for their potential in inhibiting enzymes involved in cancer progression. The chloro group serves as a handle for further functionalization via cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings, allowing for the introduction of aryl or heteroaryl groups that can enhance drug-like properties.

The ester functionality in 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester also plays a crucial role in its synthetic utility. It can be readily converted into other functional groups through hydrolysis or transesterification reactions, enabling the construction of diverse molecular architectures. This adaptability has made it a favorite among medicinal chemists who require intermediates that can be easily modified to meet specific structural requirements. Additionally, the solubility profile of this compound in common organic solvents makes it suitable for various synthetic protocols, including solid-phase synthesis and flow chemistry approaches.

Recent advances in computational chemistry have further highlighted the significance of 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester as a key intermediate. Molecular modeling studies have revealed that its scaffold can effectively interact with biological targets by occupying specific binding pockets. These insights have guided the design of analogs with improved pharmacokinetic profiles and reduced toxicity. For instance, virtual screening campaigns have identified derivatives with enhanced binding affinity to protein kinases implicated in chronic diseases. Such findings underscore the importance of this compound in modern drug discovery efforts.

The synthesis of 2-Thiazolecarboxylic acid, 4-chloro-, methyl ester itself is an intriguing process that showcases the intersection of organic synthesis and heterocyclic chemistry. Traditional methods often involve multi-step sequences starting from readily available precursors such as thioamides or halogenated thiophenes. However, recent innovations have led to more efficient synthetic routes that minimize waste and improve yields. Catalytic methods employing transition metals have been particularly successful in facilitating key transformations while maintaining high selectivity.

In conclusion,2-Thiazolecarboxylic acid, 4-chloro-, methyl ester (CAS No. 1465782-87-9) represents a cornerstone in pharmaceutical research due to its versatile reactivity and potential therapeutic applications. Its role as a building block for more complex molecules continues to drive innovation across multiple disciplines within chemical biology and medicinal chemistry. As our understanding of its properties grows through both experimental and computational studies, this compound promises to remain at the forefront of drug development efforts aimed at addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)